 | alpha-Naphthoflavone | IC50 | 50.0 [1] |
 | alpha-Naphthoflavone | Ki | 16.0 [1] |
 | Quercetin | IC50 | 77.0 [1], 1000.0 [2], 2200.0 [3] |
 | Quercetin | Ki | 23.0 [1] |
 | Acacetin | IC50 | 7.0 [1], 12.0 [2], 14.0 [3] |
 | Acacetin | Ki | 7.0 [1] |
 | 2,3',4,5'-Tetramethoxystilbene | IC50 | 2.0 [1], 6.0 [2], 300.0 [3] |
 | Chrysin | IC50 | 24.0 [1], 280.0 [2] |
 | Chrysin | Ki | 16.0 [1] |
 | (E)-1-(6-Methoxynaphthalen-2-yl)-3-pyridin-3-ylprop-2-en-1-one | IC50 | 4.0 [1], 8.0 [2], 9.0 [3], 65.0 [4] |
 | (E)-3-Naphthalen-2-yl-1-pyridin-3-ylprop-2-en-1-one | IC50 | 4.0 [1], 10.0 [2], 53.0 [3], 64.0 [4] |
 | Resveratrol | IC50 | 55000.0 [1] |
 | Resveratrol | Ki | 800.0 [1], 11200.0 [2] |
 | Apigenin | IC50 | 25.0 [1], 360.0 [2] |
 | Apigenin | Ki | 64.0 [1] |
 | Luteolin | IC50 | 79.0 [1], 360.0 [2] |
 | Luteolin | Ki | 56.0 [1] |
 | Pterostilbene | IC50 | 1400.0 [1] |
 | Pterostilbene | Ki | 900.0 [1], 910.0 [2] |
 | Diosmetin | IC50 | 29.0 [1] |
 | Diosmetin | Ki | 16.0 [1] |
 | Homoeriodictyol | IC50 | 240.0 [1], 1716.0 [2] |
 | 3-Methoxy-4',5-dihydroxy-trans-stilbene | IC50 | 2100.0 [1] |
 | 3-Methoxy-4',5-dihydroxy-trans-stilbene | Ki | 900.0 [1] |
 | (E)-5-(4-Methoxystyryl)benzene-1,3-diol | IC50 | 800.0 [1] |
 | (E)-5-(4-Methoxystyryl)benzene-1,3-diol | Ki | 2060.0 [1], 2100.0 [2] |
 | (S)-7-Hydroxy-2-(4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl)-8-(3-methylbut-2-en-1-yl)chroman-4-one | IC50 | 15000.0 [1], 20000.0 [2] |
 | 2-(4-Bromophenyl)-3,4-Dihydroquinazolin-4-One | IC50 | 3.0 [1], 25.0 [2], 60.0 [3] |
 | 2-(3-Hydroxy-4-methoxyphenyl)quinazoline-4(3H)-one | IC50 | 54.0 [1], 100.0 [2], 151.0 [3] |
 | 1-Methoxy-3-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzene | IC50 | 500.0 [1] |
 | 1-Methoxy-3-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzene | Ki | 30.0 [1], 500.0 [2] |
 | 1-Methoxy-2-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzene | IC50 | 300.0 [1] |
 | 1-Methoxy-2-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzene | Ki | 41.0 [1], 300.0 [2] |
 | 1-(4-Pyridyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one | IC50 | 5210.0 [1], 6120.0 [2], 8180.0 [3] |
 | 2-(3-Methoxy-4-hydroxyphenyl)quinazoline-4(3H)-one | IC50 | 31.0 [1], 141.0 [2], 3100.0 [3] |
 | 2-(4-Prop-2-ynoxyphenyl)-3H-quinazolin-4-one | IC50 | 2.0 [1], 32.0 [2], 70.0 [3] |
 | 2-[4-[(2,4-Difluorophenyl)methoxy]phenyl]-3H-quinazolin-4-one | IC50 | 120.0 [1], 268.0 [2] |
 | 2-[4-(2,4-Dichlorophenoxy)phenyl]-3H-quinazolin-4-one | IC50 | 4.0 [1], 66.0 [2], 149.0 [3] |
 | 2-[2-[2-[2-[2-(3-Fluorophenyl)-6,7,10-trimethoxy-4-oxobenzo[h]chromen-3-yl]oxyethoxy]ethoxy]ethoxy]ethyl 2-aminoacetate | IC50 | 12.3 [1], 25300.0 [2], 51200.0 [3] |
 | Estradiol | IC50 | 50000.0 [1] |
 | Estradiol | Ki | 1900.0 [1] |
 | Pyrene | IC50 | 2.0 [1] |
 | Kaempferol | IC50 | 47.0 [1] |
 | Kaempferol | Ki | 43.0 [1] |
 | Berberine | IC50 | 330.0 [1] |
 | Berberine | Ki | 44.0 [1] |
 | Myricetin | Ki | 27.0 [1] |
 | Isorhamnetin | IC50 | 17.0 [1] |
 | Isorhamnetin | Ki | 3.0 [1] |
 | Galangin | IC50 | 3.0 [1], 25.0 [2] |
 | Pifithrin-alpha | IC50 | 20.6 [1] |
 | Pifithrin-alpha | Ki | 4.38 [1] |
 | Rutaecarpine | IC50 | 55.0 [1] |
 | Chrysoeriol | IC50 | 19.7 [1], 20.0 [2] |
 | Oxyresveratrol | IC50 | 34000.0 [1] |
 | Isopimpinellin | IC50 | 6380.0 [1] |
 | Isopimpinellin | Ki | 11000.0 [1] |
 | Kaempferide | IC50 | 6.0 [1], 25.0 [2] |
 | Eupatorin | Ki | 35.0 [1] |
 | Hortiacine | IC50 | 84.0 [1] |
 | 3-(1-Naphthyl)-1-(4-pyridinyl)-2-propen-1-one | IC50 | 650.0 [1], 750.0 [2] |
 | (E)-3-(2-Chlorophenyl)-1-(1H-pyrrol-2-yl)prop-2-en-1-one | IC50 | 200.0 [1], 250.0 [2] |
 | 6-Methoxy-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4(9),5,7,15,17,19-octaen-14-one | IC50 | 110.0 [1] |
 | (8R,9S,13S,14S,17S)-13-Methyl-2-pyridin-4-yl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | IC50 | 32.0 [1], 240.0 [2] |
 | 7,8-Dehydrorutaecarpine | IC50 | 55.0 [1], 69.0 [2] |
 | 3-(2-Methoxyphenyl)-1-(1H-pyrrole-2-yl)-2-propene-1-one | IC50 | 900.0 [1], 1200.0 [2] |
 | 4-[3-(4-Methoxyphenyl)acryloyl]pyridine | IC50 | 7000.0 [1], 8520.0 [2] |
 | (E)-3-(4-Ethoxy-3,5-dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 610.0 [1], 698.0 [2] |
 | (E)-3-(3,5-Dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 31.0 [1], 41.0 [2] |
 | (E)-1-(1H-Pyrrol-2-yl)-3-[4-(trifluoromethoxy)phenyl]prop-2-en-1-one | IC50 | 20000.0 [1] |
 | (E)-3-(3-Ethoxy-4,5-dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 3810.0 [1], 4760.0 [2] |
 | (E)-3-(3,4-Diethoxy-5-methoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 2920.0 [1], 3070.0 [2] |
 | (E)-1-Pyridin-4-yl-3-(3,4,5-triethoxyphenyl)prop-2-en-1-one | IC50 | 8620.0 [1], 9920.0 [2] |
 | (E)-3-(1,3-Benzodioxol-5-yl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 2110.0 [1], 3520.0 [2] |
 | (E)-3-(3-Methoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 54.0 [1], 60.0 [2] |
 | (E)-3-(2-Methoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 48.0 [1], 60.0 [2] |
 | (E)-1-Pyridin-4-yl-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one | IC50 | 22.0 [1], 32.0 [2] |
 | (E)-3-(3,4-Dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-one | IC50 | 170.0 [1], 230.0 [2] |
 | 1-[(E)-2-(2,6-Dimethoxyphenyl)ethenyl]-2,4-dimethoxybenzene | IC50 | 1.77 [1], 350.0 [2] |
 | 2',3,4,4'-Tetramethoxy-trans-stilbene | IC50 | 190.0 [1], 210.0 [2] |
 | Testosterone | Ki | 411800.0 [1] |
 | Melatonin | Ki | 14000.0 [1] |
 | Fluoxetine | IC50 | 475000.0 [1] |
 | Erythromycin | IC50 | 40000.0 [1] |
 | Estrone | IC50 | 50000.0 [1] |
 | 4-Aminobenzoic acid | IC50 | 120000.0 [1] |
 | Naringenin | IC50 | 3656.0 [1] |
 | Alizarin | Ki | 500.0 [1] |
 | Baicalein | Ki | 260.0 [1] |
 | Flavone | IC50 | 600.0 [1] |
 | 2-Methoxyestradiol | Ki | 36000.0 [1] |
 | 3-Hydroxyflavone | IC50 | 90.0 [1] |
 | Plumbagin | IC50 | 6150.0 [1] |
 | Hesperetin | IC50 | 511.0 [1] |
 | Khellin | IC50 | 34600.0 [1] |
 | 3,3',4,4',5-Pentachlorobiphenyl | IC50 | 11.0 [1] |
 | Formononetin | Ki | 3700.0 [1] |
 | Bergapten | IC50 | 15300.0 [1] |
 | Biochanin A | Ki | 1900.0 [1] |
 | Imperatorin | Ki | 1000.0 [1] |